International Journal of Clinical Research

Objective: To observe the clinical value of plain enhanced MRI combined with perfusion imaging (PWI) in the diagnosis of craniocerebral tumor diseases. Methods: A total of 94 patients with suspected craniocerebral tumor diseases admitted to our hospital from January 2021 to May 2022 were selected as observation samples. All the enrolled patients received plain ENHANCED MRI and PWI examination, and the surgical situation and pathological results were followed up. The pathological results were taken as the gold standard for diagnosis, and the sensitivity, specificity and accuracy of plain enhanced MRI and PWI examination in the diagnosis of cranial tumor diseases were analyzed. Results: In this group of 94 suspected patients with craniocerebral tumor disease, 86 cases were confirmed as craniocerebral tumor, including 35 cases of glioma, 31 cases of meningioma, 12 cases of brain metastasis and 8 cases of lymphoma. With postoperative pathological results as the gold standard, the sensitivity, specificity and accuracy of MRI plain enhanced diagnosis were 96.9%, 20.7% and 73.4% respectively. The sensitivity, specificity and accuracy of MRI combined with PWI were 97.6%, 60.0% and 93.6% respectively. Conclusion: In the diagnosis of craniocerebral tumor diseases, MRI plain scan enhancement combined with PWI has high sensitivity and accuracy, which can provide reliable basis for clinical diagnosis and has high clinical application value.

Perfusion imaging; Magnetic resonance imaging (MRI); Craniocerebral tumor; The sensitivity